Beijing Tongrentang Co., Ltd (SHA: 600085)

Market Cap	54.24B
Revenue (ttm)	17.96B
Net Income (ttm)	1.63B
Shares Out	1.37B
EPS (ttm)	1.19
PE Ratio	33.32
Forward PE	34.39
Dividend	0.50 (1.23%)
Ex-Dividend Date	Oct 10, 2024

Volume	9,432,084
Open	40.50
Previous Close	40.59
Day's Range	39.26 - 41.08
52-Week Range	30.84 - 55.10
Beta	0.28
Analysts	n/a
Price Target	n/a
Earnings Date	Mar 29, 2025

About Beijing Tongrentang

Beijing Tongrentang Co., Ltd engages in the scientific research, production, distribution, and sale of Chinese medicines in China. The company provides product dosage forms, such as pills, powders, wine preparations, capsules, and oral liquids in the areas of cardiovascular, gynecology, heat clearing class, respiratory system, nourishing and calming, digestive system, pediatrics, wind-dispelling and dampness-removing, orthopedics, five senses, dermatology, psychological, and food and wine. The company was founded in 1997 and is headquartered in...

• Industry: Drug Manufacturers - Specialty & Generic
• Sector: Healthcare
• Founded: 1997
• Employees: 16,777
• Stock Exchange: Shanghai Stock Exchange
• Ticker Symbol: 600085

Financial Performance

In 2023, Beijing Tongrentang's revenue was 17.86 billion, an increase of 16.19% compared to the previous year's 15.37 billion. Earnings were 1.67 billion, an increase of 16.92%.